Skip to content
Creatinine Clearance Calculator · the Gault Standard
Menu

Vancomycin AUC Dosing Calculator

An educational first-dose estimate, not a substitute for TDM.

Estimate initial vancomycin loading and maintenance dosing by weight and creatinine clearance.

Medically reviewed by Dr. Rishi Kumar Kafle, MBBS, MD, FASN. Last reviewed October 2026.

Unit
mL/min

This is an educational first-dose estimate only. Current practice targets an AUC of 400-600 mg·h/L with Bayesian or two-level monitoring. This tool does not replace therapeutic drug monitoring.

Enter weight and creatinine clearance for an educational dosing estimate.

Estimates only · reviewed and approved. Use your institution's TDM protocol.

IV infusion bag on a pole beside a hospital bed
In hospital, kidney function can change within days, so estimates are repeated. Illustrative image.

This vancomycin AUC dosing calculator gives an educational first-dose estimate for vancomycin from weight and creatinine clearance, targeting an AUC of 400-600 mg·h/L. It is a starting point only. It does not replace Bayesian or two-level therapeutic drug monitoring (TDM), which remains essential for safe vancomycin therapy.

Why AUC-Guided Dosing

Vancomycin's effectiveness against MRSA tracks with its total exposure: the area under the concentration-time curve (AUC) over a 24-hour period, relative to the organism's MIC. The 2020 consensus guideline targets an AUC of 400-600 mg·h/L. It moves away from the older practice of chasing high troughs (15-20 mg/L), which exposed patients to more kidney injury for no added benefit. Because vancomycin is cleared renally, the rate at which a patient eliminates it (captured by creatinine clearance) sets how much is needed to reach that exposure.

The Starting Components

  • Loading dose: about 25-30 mg/kg of actual body weight, given once to reach therapeutic levels quickly. It is independent of kidney function because it fills the body's volume of distribution rather than replacing what is cleared.
  • Maintenance dose: about 15 mg/kg per dose, with the interval lengthening as creatinine clearance falls: every 8-12 hours in good kidney function, and every 24 hours or longer in marked impairment.

Worked Example

Consider an 80 kg patient with a creatinine clearance of about 90 mL/min. A loading dose at 25 mg/kg is 25 × 80 = 2000 mg. Maintenance at 15 mg/kg is 15 × 80 = 1200 mg, and with near-normal clearance that would typically be given about every 12 hours as a first estimate. Measured levels then confirm and adjust these figures, which are never assumed correct on the estimate alone.

How the Interval Tracks Creatinine Clearance

Typical starting maintenance interval by creatinine clearance (estimate only)
Creatinine clearanceTypical starting interval
> 90 mL/minEvery 8-12 hours
50-90 mL/minEvery 12 hours
20-49 mL/minEvery 24 hours
< 20 mL/minExtended interval, level-guided

These intervals are a first-dose guide only. Measured vancomycin levels set and revise the actual schedule.

Loading vs Maintenance: Two Different Jobs

The loading and maintenance doses of vancomycin solve two different problems. The loading dose exists to fill the body's volume of distribution quickly, so the drug reaches a therapeutic concentration in hours rather than days. Because it is about volume, not clearance, it is given on body weight and is the same whether the kidneys are healthy or failing. A patient in kidney failure still needs a full loading dose to get to target promptly. The maintenance dose, by contrast, replaces what the kidneys remove between doses, so it must track creatinine clearance: as clearance falls, the same dose is spaced further apart to avoid accumulation. Confusing the two is a common and avoidable error, whether that means withholding a loading dose in renal impairment or failing to lengthen the maintenance interval.

How the Estimate Is Refined by Levels

This calculator produces a first estimate, and measured drug levels then refine it during therapy. Two approaches dominate. Bayesian software takes one or two early levels and the patient's characteristics and projects the full 24-hour AUC. That allows a dose adjustment after a single check. Alternatively, two timed levels, a peak and a trough within one dosing interval, let the AUC be calculated directly. Either way, the measured exposure is compared against the 400-600 mg·h/L target and the dose or interval is adjusted up or down. Kidney function is rechecked through therapy, because vancomycin clearance can change quickly in acute illness, and a regimen that was correct on day one can drift out of range by day three. The estimate sets the starting dose, and monitoring keeps the AUC inside the target window.

What AUC of 400-600 Represents

The vancomycin AUC target window is a balance between effectiveness and kidney safety. Below an AUC of about 400 mg·h/L (against a typical MIC of 1), vancomycin is less likely to clear a serious MRSA infection. Above about 600 mg·h/L, the risk of acute kidney injury climbs without added benefit. Aiming for the 400-600 band, confirmed by measured levels, keeps the patient in the range where the drug is both effective and as safe as it reasonably can be. This is why modern practice tracks the full 24-hour exposure rather than a single trough level. Two patients with the same trough can have quite different total exposures, and it is the exposure that drives both treatment success and harm.

A Second Worked Example

Consider a 60 kg patient with a creatinine clearance of about 35 mL/min. The loading dose at 25 mg/kg is 25 × 60 = 1500 mg, unchanged by the reduced clearance. The maintenance dose at 15 mg/kg is 15 × 60 = 900 mg, but with clearance in the 20-49 mL/min band it would typically start at every 24 hours rather than every 12. The longer interval is how the regimen adapts to slower elimination. Measured levels then confirm whether that interval holds the AUC in range.

Limitations and Cautions

  • This is an educational first-dose estimate, not a substitute for therapeutic drug monitoring. Confirm exposure with Bayesian software or two timed levels.
  • Estimated creatinine clearance is least reliable in unstable kidney function, where it lags behind true clearance and can mislead dosing.
  • Obesity, critical illness, dialysis, and rapidly changing renal function all alter vancomycin handling beyond what a simple estimate captures.
  • Monitor kidney function and vancomycin levels throughout therapy; AUC above 600 mg·h/L raises the risk of nephrotoxicity.

See vancomycin renal dosing for the threshold table and the renal drug dosing hub for other agents.

Frequently Asked Questions

What AUC should vancomycin target?

Current guidelines target an AUC of 400-600 mg·h/L, guided by Bayesian software or two measured levels. A loading dose of about 25-30 mg/kg and maintenance near 15 mg/kg are common starting points.

Why has trough-based dosing been replaced by AUC?

AUC-guided dosing achieves the target exposure with less kidney injury than aiming for high troughs of 15-20 mg/L. The 2020 consensus guideline recommends targeting an AUC of 400-600 mg·h/L instead of trough-only monitoring.

What weight is used for vancomycin dosing?

Vancomycin is dosed on actual (total) body weight for both loading and maintenance, including in most obese patients, with a maximum practical single dose often applied. Doses are then refined by measured levels.

Can this calculator replace drug-level monitoring?

No. It provides an educational first-dose estimate only. Actual therapy must be guided by measured vancomycin levels, Bayesian software or two timed levels, to confirm the AUC and adjust the dose.

References

  1. Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin: ASHP/IDSA/PIDS/SIDP consensus guideline. Am J Health-Syst Pharm. 2020;77(11):835-864.
  2. DailyMed (U.S. National Library of Medicine). FDA drug labeling.

Medical review by Dr. Rishi Kumar Kafle

MBBS, MD, FASN, Consultant Nephrologist

Nepal Mediciti, Kathmandu

Last reviewed October 2026. The reviewer checks equation use, normal ranges, CKD cutoffs and renal dosing thresholds against current guidance before a page is presented as authoritative.